MF
RMD icon

Milford Funds’s ResMed RMD Stock Holding History

Milford Funds’s Portfolio RMD Stock Details RMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.95M Sell
10,000
-140,000
-93% -$29M 0.03% 80
2026
Q1 		$33.7M Buy
150,000
+32,000
+27% +$7.97M 0.71% 40
2025
Q4 		$28.4M Buy
+118,000
New +$30.2M 0.56% 46

Other funds holding RMD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
First Trust Advisors
First Trust Advisors Wheaton, Illinois $170B AUM 46.21% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Milford Funds's RMD Position: Q2 2026 in Review

Milford Funds reduced its ResMed (RMD) stake by 93% in Q2 2026, selling an estimated $29M and leaving 10,000 shares worth $1.95M. The position accounts for 0.03% of the portfolio, ranked #80.

Milford Funds first reported a position in RMD in Q4 2025 and has held it in 3 quarters since. The position peaked at $33.7M in Q1 2026. 891 funds tracked by Wall St. Rank hold RMD as of Q2 2026.

  • Milford Funds held 10,000 shares of ResMed worth $1.95M as of Q2 2026.
  • Milford Funds sold 140,000 ResMed shares in Q2 2026, an estimated $29M.
  • ResMed made up 0.03% of Milford Funds's portfolio in Q2 2026, its #80 holding.
  • Milford Funds first reported a position in ResMed in Q4 2025 and has held it in 3 quarters since.
  • Milford Funds's ResMed position peaked at $33.7M in Q1 2026.
  • 891 funds tracked by Wall St. Rank held ResMed as of Q2 2026.

Based on Milford Funds's 13F filing for Q2 2026, filed 30 Jul 2026.